Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Am J Gastroenterol. 2014 Nov 18;109(12):1910–1921. doi: 10.1038/ajg.2014.330

Figure 5.

Figure 5

Relation Between Moderate or More severe Symptoms and Plasma Enteral Hormone Concentrations During Dextrose (A) and Lipid (B) Infusions. Moderate or more severe symptoms were associated with high plasma hormone levels of glucagonlike peptide 1 (GLP1) during dextrose infusion and of cholecystokinin (CCK) and glucose-dependent insulinotropic peptide (GIP) during lipid infusion. PYY indicates peptide YY.